Literature DB >> 22577079

Functional characterization of the human RPGR proximal promoter.

Xinhua Shu1, Julie R Simpson, Alan W Hart, Zhihong Zeng, Sarita Rani Patnaik, Philippe Gautier, Emma Murdoch, Brian Tulloch, Alan F Wright.   

Abstract

PURPOSE: Mutations in the retinitis pigmentosa (RP) GTPase regulator (RPGR) gene account for more than 70% of X-linked RP cases. This study aims to characterize the proximal promoter region of the human RPGR gene.
METHODS: The 5'-flanking region (5 kb) of human RPGR was cloned and sequenced. A potential transcription start site and transcription factor binding motifs were identified by bioinformatic analysis. Constructs containing the putative human RPGR promoter region upstream of a luciferase reporter gene were generated and analyzed by transient transfection and luciferase assays. Transgenic mouse lines carrying a 3-kb human RPGR promoter sequence fused to lacZ were generated and RPGR proximal promoter activity was analyzed by X-gal staining.
RESULTS: Bioinformatic analyses of the human RPGR 5'-flanking region uncovered potential transcription factor binding sites and a CpG island. Transient transfection assays with RPGR promoter/luciferase reporter constructs revealed a 980-bp fragment (-952 to +28) that produced higher levels of luciferase activity. Mutagenesis identified a putative Sp1 binding site that was critical for regulating transcriptional activity. We generated transgenic mice in which a lacZ reporter gene was controlled by the 3-kb upstream region of RPGR. β-galactosidase expression was predominantly found in mouse retina, brain, and kidney. In the retina, the photoreceptor cell layer showed the strongest β-galactosidase staining.
CONCLUSIONS: Our study defined the human RPGR proximal promoter region in which a 3-kb fragment contained sufficient regulatory elements to control RPGR expression in mouse retina and other tissues. Characterization of the RPGR promoter will facilitate understanding of the functional role of RPGR in the retina and gene therapy of X-linked RP.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22577079     DOI: 10.1167/iovs.11-8811

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  5 in total

1.  RPGR-associated retinal degeneration in human X-linked RP and a murine model.

Authors:  Wei Chieh Huang; Alan F Wright; Alejandro J Roman; Artur V Cideciyan; Forbes D Manson; Dina Y Gewaily; Sharon B Schwartz; Sam Sadigh; Maria P Limberis; Peter Bell; James M Wilson; Anand Swaroop; Samuel G Jacobson
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-08-15       Impact factor: 4.799

Review 2.  Gene augmentation for X-linked retinitis pigmentosa caused by mutations in RPGR.

Authors:  William A Beltran; Artur V Cideciyan; Alfred S Lewin; William W Hauswirth; Samuel G Jacobson; Gustavo D Aguirre
Journal:  Cold Spring Harb Perspect Med       Date:  2014-10-09       Impact factor: 6.915

Review 3.  Gene therapy for retinal disease.

Authors:  Michelle E McClements; Robert E MacLaren
Journal:  Transl Res       Date:  2013-01-08       Impact factor: 7.012

Review 4.  Advances in gene therapy technologies to treat retinitis pigmentosa.

Authors:  Hilda Petrs-Silva; Rafael Linden
Journal:  Clin Ophthalmol       Date:  2013-12-24

Review 5.  RPGR: Its role in photoreceptor physiology, human disease, and future therapies.

Authors:  Roly D Megaw; Dinesh C Soares; Alan F Wright
Journal:  Exp Eye Res       Date:  2015-06-17       Impact factor: 3.467

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.